Brief: Relief Says Aviptadil Selected For NIH-Sponsored Global Trial

MindMaze Therapeutics Holding SA

07/04/2021 06:05

April 7 (Reuters) - RELIEF THERAPEUTICS HOLDING SA  RLFB.S :
    * RELIEF REPORTS THAT NEURORX HAS ANNOUNCED THAT AVIPTADIL
HAS
BEEN SELECTED FOR INCLUSION IN NIH-SPONSORED GLOBAL CLINICAL
TRIAL WHICH INCLUDES AVIPTADIL AND REMDESIVIR

Source text for Eikon:  ID:nEQ5vXZvka 
Further company coverage:  RLFB.S 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))